Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation?

Cesare Cuspidi, Rita Facchetti, Carla Sala, Michele Bombelli, Marijana Tadic, Guido Grassi, Giuseppe Mancia

Research output: Contribution to journalArticle

Abstract

The authors estimated the risk of cardiovascular mortality associated with echocardiographic (ECHO) left ventricular hypertrophy (LVH) and subtypes of this phenotype in patients with and without electrocardiographic (ECG) LVH. A total of 1691 representatives of the general population were included in the analysis. During a follow-up of 211 months, 89 cardiovascular deaths were recorded. Compared with individuals with neither ECHO LVH nor ECG LVH, fully adjusted risk of cardiovascular mortality increased (hazard ratio [HR], 3.36; 95% confidence interval [CI], 1.51–7.47; P=.003) in patients with both ECHO-LVH and ECG-LVH, whereas the risk entailed by ECHO-LVH alone was of borderline statistical significance (P=.04). Combined concentric nondilated LVH and ECG-LVH, but not concentric nondilated LVH alone, predicted cardiovascular death (HR, 3.79; 95% CI, 1.25–11.38; P=.01). Similar findings were observed for eccentric nondilated LVH (HR, 3.37; 95% CI, 1.05–10.78; P=.04.). The present analysis underlines the value of combining ECG and ECHO in the assessment of cardiovascular prognosis related to abnormal left ventricular geometric patterns.

Original languageEnglish
Pages (from-to)846-854
Number of pages9
JournalJournal of Clinical Hypertension
Volume18
Issue number9
DOIs
Publication statusPublished - Sep 1 2016

Fingerprint

Left Ventricular Hypertrophy
Confidence Intervals
Mortality
Phenotype

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine

Cite this

Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation? / Cuspidi, Cesare; Facchetti, Rita; Sala, Carla; Bombelli, Michele; Tadic, Marijana; Grassi, Guido; Mancia, Giuseppe.

In: Journal of Clinical Hypertension, Vol. 18, No. 9, 01.09.2016, p. 846-854.

Research output: Contribution to journalArticle

Cuspidi, Cesare ; Facchetti, Rita ; Sala, Carla ; Bombelli, Michele ; Tadic, Marijana ; Grassi, Guido ; Mancia, Giuseppe. / Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation?. In: Journal of Clinical Hypertension. 2016 ; Vol. 18, No. 9. pp. 846-854.
@article{49e3e8305503457096bfe0a65e1c6db5,
title = "Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation?",
abstract = "The authors estimated the risk of cardiovascular mortality associated with echocardiographic (ECHO) left ventricular hypertrophy (LVH) and subtypes of this phenotype in patients with and without electrocardiographic (ECG) LVH. A total of 1691 representatives of the general population were included in the analysis. During a follow-up of 211 months, 89 cardiovascular deaths were recorded. Compared with individuals with neither ECHO LVH nor ECG LVH, fully adjusted risk of cardiovascular mortality increased (hazard ratio [HR], 3.36; 95{\%} confidence interval [CI], 1.51–7.47; P=.003) in patients with both ECHO-LVH and ECG-LVH, whereas the risk entailed by ECHO-LVH alone was of borderline statistical significance (P=.04). Combined concentric nondilated LVH and ECG-LVH, but not concentric nondilated LVH alone, predicted cardiovascular death (HR, 3.79; 95{\%} CI, 1.25–11.38; P=.01). Similar findings were observed for eccentric nondilated LVH (HR, 3.37; 95{\%} CI, 1.05–10.78; P=.04.). The present analysis underlines the value of combining ECG and ECHO in the assessment of cardiovascular prognosis related to abnormal left ventricular geometric patterns.",
author = "Cesare Cuspidi and Rita Facchetti and Carla Sala and Michele Bombelli and Marijana Tadic and Guido Grassi and Giuseppe Mancia",
year = "2016",
month = "9",
day = "1",
doi = "10.1111/jch.12834",
language = "English",
volume = "18",
pages = "846--854",
journal = "Journal of clinical hypertension",
issn = "1524-6175",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation?

AU - Cuspidi, Cesare

AU - Facchetti, Rita

AU - Sala, Carla

AU - Bombelli, Michele

AU - Tadic, Marijana

AU - Grassi, Guido

AU - Mancia, Giuseppe

PY - 2016/9/1

Y1 - 2016/9/1

N2 - The authors estimated the risk of cardiovascular mortality associated with echocardiographic (ECHO) left ventricular hypertrophy (LVH) and subtypes of this phenotype in patients with and without electrocardiographic (ECG) LVH. A total of 1691 representatives of the general population were included in the analysis. During a follow-up of 211 months, 89 cardiovascular deaths were recorded. Compared with individuals with neither ECHO LVH nor ECG LVH, fully adjusted risk of cardiovascular mortality increased (hazard ratio [HR], 3.36; 95% confidence interval [CI], 1.51–7.47; P=.003) in patients with both ECHO-LVH and ECG-LVH, whereas the risk entailed by ECHO-LVH alone was of borderline statistical significance (P=.04). Combined concentric nondilated LVH and ECG-LVH, but not concentric nondilated LVH alone, predicted cardiovascular death (HR, 3.79; 95% CI, 1.25–11.38; P=.01). Similar findings were observed for eccentric nondilated LVH (HR, 3.37; 95% CI, 1.05–10.78; P=.04.). The present analysis underlines the value of combining ECG and ECHO in the assessment of cardiovascular prognosis related to abnormal left ventricular geometric patterns.

AB - The authors estimated the risk of cardiovascular mortality associated with echocardiographic (ECHO) left ventricular hypertrophy (LVH) and subtypes of this phenotype in patients with and without electrocardiographic (ECG) LVH. A total of 1691 representatives of the general population were included in the analysis. During a follow-up of 211 months, 89 cardiovascular deaths were recorded. Compared with individuals with neither ECHO LVH nor ECG LVH, fully adjusted risk of cardiovascular mortality increased (hazard ratio [HR], 3.36; 95% confidence interval [CI], 1.51–7.47; P=.003) in patients with both ECHO-LVH and ECG-LVH, whereas the risk entailed by ECHO-LVH alone was of borderline statistical significance (P=.04). Combined concentric nondilated LVH and ECG-LVH, but not concentric nondilated LVH alone, predicted cardiovascular death (HR, 3.79; 95% CI, 1.25–11.38; P=.01). Similar findings were observed for eccentric nondilated LVH (HR, 3.37; 95% CI, 1.05–10.78; P=.04.). The present analysis underlines the value of combining ECG and ECHO in the assessment of cardiovascular prognosis related to abnormal left ventricular geometric patterns.

UR - http://www.scopus.com/inward/record.url?scp=84988476753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988476753&partnerID=8YFLogxK

U2 - 10.1111/jch.12834

DO - 10.1111/jch.12834

M3 - Article

VL - 18

SP - 846

EP - 854

JO - Journal of clinical hypertension

JF - Journal of clinical hypertension

SN - 1524-6175

IS - 9

ER -